Coinbase Global, Inc. vs Cytokinetics Inc — how do they compare? Coinbase Global, Inc. trades at $150.3 (market cap $39.20B), while Cytokinetics Inc trades at $77.39 (market cap $10.63B). The key difference: Coinbase Global, Inc. is far larger — about 3.7× Cytokinetics Inc's market cap, and Cytokinetics Inc is trading nearer its 52-week high, Coinbase Global, Inc. nearer its low. Which is the better fit depends on your goals.
| COIN | CYTK | |
|---|---|---|
Market Cap | $39.20B | $10.63B |
Sector | Technology | Technology |
52-Week High | $387.27 | $87.26 |
52-Week Low | $141.09 | $34.31 |
Enterprise Value | $36.85B | $10.74B |
Trailing returns across standard periods
Latest headlines on both assets
Coinbase Global, Inc. is a regulated cryptocurrency company that provides customers around the world with a platform for buying, selling, transferring, and storing digital assets. The Company offers a variety of products and services that enable individuals, businesses, and developers to participate in the cryptoeconomy.
Read more on COIN →Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →